Opportunity

Federal Register #2026-20535

DEA revokes Arenbii Pharmacy LLC’s controlled-substance registration

Posted

October 07, 2026

Identifier

2026-20535

The DEA order revokes Arenbii Pharmacy LLC’s controlled-substance registration; this notice is not a procurement opportunity. - Government agency: U.S. Department of Justice, Drug Enforcement Administration (DEA). - Entity addressed: Arenbii Pharmacy LLC, located in Missouri City, Texas. - The DEA revoked the pharmacy’s registration after it failed to request a hearing in response to an Order to Show Cause and Immediate Suspension of Registration, resulting in a default. - The order concerns allegations that the pharmacy repeatedly filled Schedule II controlled-substance prescriptions despite red flags for abuse or diversion, without properly addressing or resolving those concerns. - The revocation also applies to Arenbii Pharmacy LLC’s pending applications to renew, modify, or obtain additional DEA registrations in Texas. - No products, services, quantities, part numbers, OEMs, or procurement vendors are identified.

Description

The Drug Enforcement Administration issued a Decision and Order concerning Arenbii Pharmacy LLC, a DEA registrant in Missouri City, Texas. The order revokes the pharmacy’s DEA registration after it defaulted by failing to request a hearing in response to an Order to Show Cause and Immediate Suspension of Registration. The notice states the allegations involved filling Schedule II controlled-substance prescriptions despite red flags of abuse or diversion without addressing or resolving them. The revocation order is effective November 6, 2026.

View original listing